These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9377523)

  • 1. Lack of correlation between gallbladder opacification in delayed CT and contrast-associated nephropathy.
    Yamazaki H; Oi H; Matsushita M; Kim T; El-Baradie M; Inoue T; Teshima T; Koizumi M; Nose T; Tanaka E; Nakamura H; Inoue T
    Eur Radiol; 1997; 7(8):1328-31. PubMed ID: 9377523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallbladder opacification 12-24 h after angiography by CT examination: a multivariate analysis.
    Yamazaki H; Oi H; Matsushita M; Teshima T; Murayama S; Nose T; Koizumi T; Tanaka E
    Abdom Imaging; 1996; 21(6):507-11. PubMed ID: 8875872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CT assessment of gallbladder opacification 12-24 hours after angiography].
    Yamazaki H; Oi H; Matsushita M; Kim T; Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1281-6. PubMed ID: 1437533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cortical retention on delayed CT after angiography and contrast associated nephropathy.
    Yamazaki H; Oi H; Matsushita M; Inoue T; Teshima T; Koizumi M; Nose T; Tanaka E; Nakamura H; Inoue T; Kim T; Elbaradie MM
    Br J Radiol; 1997 Sep; 70(837):897-902. PubMed ID: 9486065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal residual contrast media in the kidney 24 hours after angiography.
    Yamazaki H; Oi H; Matsushita M; Koizumi M; Kagawa K; Tanaka E; Murayama S; Nose T; Teshima T; Inoue TA; Inoue TO
    Acta Radiol; 1996 May; 37(3 Pt 1):348-51. PubMed ID: 8845267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
    Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
    AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cortical retention of contrast medium on delayed CT and nephropathy following transcatheter arterial chemoembolisation in patients with high serum creatinine level.
    Yamazaki H; Oi H; Matshushita M; Inoue T; Nakamura H; Inoue T
    Br J Radiol; 2002 Nov; 75(899):874-8. PubMed ID: 12466251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent CT nephrogram: significance in the diagnosis of contrast nephropathy.
    Love L; Lind JA; Olson MC
    Radiology; 1989 Jul; 172(1):125-9. PubMed ID: 2740495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of persistent renal dysfunction after contrast enhanced coronary CT angiography in patients with suspected coronary artery disease.
    Maaniitty T; Stenström I; Uusitalo V; Ukkonen H; Kajander S; Bax JJ; Saraste A; Knuuti J
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1567-75. PubMed ID: 27405562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cortical retention on delayed CT and nephropathy following transcatheter arterial chemoembolisation.
    Yamazaki H; Oi H; Matsushita M; Kim T; Tanaka E; Inoue T; Nakamura H; Teshima T; Inoue T
    Br J Radiol; 2001 Aug; 74(884):695-700. PubMed ID: 11511493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
    Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; Guimarães MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
    PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
    Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
    Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
    Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
    AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
    El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
    Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography.
    Krol AL; Dzialowski I; Roy J; Puetz V; Subramaniam S; Coutts SB; Demchuk AM
    Stroke; 2007 Aug; 38(8):2364-6. PubMed ID: 17600231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium:nonionic contrast media (1:1) coronary angiography in patients with impaired renal function.
    Sayin T; Turhan S; Akyürek O; Kilickap M
    Angiology; 2007; 58(5):561-4. PubMed ID: 17906283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
    Ng CS; Shaw AD; Bell CS; Samuels JA
    AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.